Previous 10 | Next 10 |
2023-04-28 10:03:38 ET Gainers: Tempest Therapeutics ( TPST ) +72% . CVRx ( CVRX ) +25% . ImmunoGen ( IMGN ) +22% . Apyx Medical ( APYX ) +17% . bluebird bio ( BLUE ) +17% . Losers: Hillstream BioPharma ( HILS ) -56%...
2023-04-28 08:15:57 ET The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Apyx Medical's ( NASDAQ: APYX ) Renuvion APR Handpiece for coagulation of subcutaneous soft tissues after liposuction for aesthetic body contouring. "The Renuvion APR handpiece ...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial results for the first quarter of fiscal year 2023 will be released before...
Renuvion Wins ADDY® Award for #ThisIsMe Campaign PR Newswire Advertising Industry's Largest Competition Recognizes Apyx Medical Device Campaign for Excellence in the Art of Advertising CLEARWATER, Fla. , March 27, 2023 /PRNewswire/ -- Apyx Medical Corp...
2023-03-16 11:30:05 ET Apyx Medical Corporation (APYX) Q4 2022 Earnings Conference Call March 16, 2023 8:00 AM ET Company Participants Charles Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants ...
2023-03-16 07:03:55 ET Apyx Medical press release ( NASDAQ: APYX ): Q4 GAAP EPS of -$0.17 misses by $0.03 . Revenue of $12.61M (-25.0% Y/Y) misses by $0.43M . Advanced Energy revenue of $10.5 million, down 30% year-over-year. OEM revenue of $2.1 million, up...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported financial results for its fourth quarter and full year ended December 31, 2022, and introduced ...
Medical tech company Apyx Medical Corporation ( NASDAQ: APYX ) announced Monday that the FDA issued 510(k) clearance to use its Renuvion APR Handpiece in certain soft tissue-related medical procedures. Specifically, the new indication for the device covers the delivery of radiofrequen...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA...
News, Short Squeeze, Breakout and More Instantly...
Apyx Medical Corporation Company Name:
APYX Stock Symbol:
NASDAQ Market:
Apyx Medical Corporation Website:
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health PR Newswire Renuvion is the only device FDA-cleared for contracting subcutaneous tissue CLEARWATER, Fla. ...
Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today reported financial results for its first quarter ended March 31, 202...